Short communication · 21 Jun 2021
Research articlePublished 1 Aug 2017
Treatment of rotenone induced neurodegeneration by taurine and hesperidin
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Taurine (2-aminoethane sulphonic acid) is a sulphonic acid which is derived from cysteine and is widely distributed in animal tissues. It is one of the most abundant amino acid in mammals and plays several crucial roles including modulation of calcium signaling, osmoregulation and membrane stabilization. Hesperidin occurs in the cells in crystalline, feather-like aggregates or sphaerocrytalline masses and it exhibits pharmacological and biological properties such as anti-inflammatory, anticarcinogenic, inhibit bone loss, lowering of lipid, hypoglycaemic and antioxidant activities. The current study was performed to evaluate the effect of taurine and hesperidin on neurodegeneration resulted from rotenone administration by a dose of 1.5 mg/kg b.wt three times per week for two months. Also we summarize recent findings emphasizing the role of catecholamines neurotransmitters, Tyrosine hydroxylase and oxidative stress in neurodegenerative disease model. These rats received taurine and hesperidin through gastric intubation daily for one month after rotenone administration. The results revealed that taurine and hesperidin treatment significantly ameliorated the decreased levels of the catecholamines neurotransmitters and Tyrosine hydroxylase which were decreased as after rotenone injection. Moreover, taurine and hesperidin treatment ameliorated lipid peroxidation and catalase levels.
Subjects
Neuroscience & NeurologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in International Journal of Bioassays.
Short communication · 21 Jun 2021
Pharmacology and Chromatography and HPLC Congress 2018: Role of biobanking in discovering pharmacologic biomarker targets for the practice of precision medicine - Richard L Summers - University of Mississippi Medical Center
Short communication · 21 Jun 2021
Pharmacology and Chromatography and HPLC Congress 2018: Glycyl - lutamine: A new hope in the treatment of depression? - Sinan Cavun - Uludag University
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalInternational Journal of Bioassays
- SubjectNeuroscience & Neurology
- BylineArticles whose byline prints “Eman S. Abdel-Reheim”
- BylineArticles whose byline prints “Basant M. Mahmoud”
- BylineArticles whose byline prints “Hanan A. Soliman”
- BylineArticles whose byline prints “Basma S. Ismail”